JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 26, 2001
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
276/5/3543    most recent
M007231200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ravichandran, L. V.
Right arrow Articles by Quon, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ravichandran, L. V.
Right arrow Articles by Quon, M. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print November 3, 2000
J. Biol. Chem, 10.1074/jbc.M007231200
Submitted on August 9, 2000
Revised on November 1, 2000
Accepted on November 3, 2000

PKC-zeta phosphorylates IRS-1 and impairs its ability to activate PI 3-kinase in response to insulin

Lingamanaidu V. Ravichandran, Diana L. Esposito, Judy Chen, and Michael J. Quon

Cardiology Branch, NHLBI, National Institutes of Health, Bethesda, MD 20892-1755

Corresponding Author: quonm{at}nih.gov

PKC-zeta is a serine-threonine kinase downstream from PI 3-kinase in insulin signaling pathways. However, specific substrates for PKC-zeta that participate in biological actions of insulin have not been reported. In the present study, we identified IRS-1 as a novel substrate for PKC-zeta . Under in vitro conditions, wild-type PKC-zeta (but not kinase-deficient mutant PKC-zeta ) significantly phosphorylated IRS-1. This phosphorylation was reversed by treatment with the serine-specific phosphatase PP-2A. In addition, overexpression of PKC-zeta in NIH-3T3IR cells caused significant phosphorylation of co-transfected IRS-1 as demonstrated by [32P]-orthophosphate labeling experiments. In rat adipose cells, endogenous IRS-1 co-immunoprecipitated with endogenous PKC-zeta and this association was increased 2-fold upon insulin stimulation. Furthermore, overexpression of PKC-zeta in NIH-3T3IR cells significantly impaired insulin-stimulated tyrosine phosphorylation of co-transfected IRS-1. Importantly, this was accompanied by impaired IRS-1-associated PI 3-kinase activity. Taken together, our results raise the possibility that IRS-1 is a novel physiological substrate for PKC-zeta . Since PKC-zeta is located downstream from IRS-1 and PI 3-kinase in established insulin signaling pathways, PKC-zeta may participate in negative feedback pathways to IRS-1 similar to those previously described for Akt and GSK-3.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
K. Morino, S. Neschen, S. Bilz, S. Sono, D. Tsirigotis, R. M. Reznick, I. Moore, Y. Nagai, V. Samuel, D. Sebastian, et al.
Muscle-Specific IRS-1 Ser->Ala Transgenic Mice Are Protected From Fat-Induced Insulin Resistance in Skeletal Muscle
Diabetes, October 1, 2008; 57(10): 2644 - 2651.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Schmitz-Peiffer and T. J. Biden
Protein Kinase C Function in Muscle, Liver, and {beta}-Cells and Its Therapeutic Implications for Type 2 Diabetes
Diabetes, July 1, 2008; 57(7): 1774 - 1783.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Z. Liberman, B. Plotkin, T. Tennenbaum, and H. Eldar-Finkelman
Coordinated phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 and protein kinase C{beta}II in the diabetic fat tissue
Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1169 - E1177.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Lee, E. G. Lynn, J.-a Kim, and M. J. Quon
Protein Kinase C-{zeta} Phosphorylates Insulin Receptor Substrate-1, -3, and -4 But Not -2: Isoform Specific Determinants of Specificity in Insulin Signaling
Endocrinology, May 1, 2008; 149(5): 2451 - 2458.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Sharfi and H. Eldar-Finkelman
Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling
Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E307 - E315.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
W.-Q. Zhao, F. G. De Felice, S. Fernandez, H. Chen, M. P. Lambert, M. J. Quon, G. A. Krafft, and W. L. Klein
Amyloid beta oligomers induce impairment of neuronal insulin receptors
FASEB J, January 1, 2008; 22(1): 246 - 260.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Tremblay, S. Brule, S. Hee Um, Y. Li, K. Masuda, M. Roden, X. J. Sun, M. Krebs, R. D. Polakiewicz, G. Thomas, et al.
Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance
PNAS, August 28, 2007; 104(35): 14056 - 14061.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. G. Kang, A. L. Brown, and J. H. Chung
Oxygen Tension Regulates the Stability of Insulin Receptor Substrate-1 (IRS-1) through Caspase-mediated Cleavage
J. Biol. Chem., March 2, 2007; 282(9): 6090 - 6097.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Fediuc, M. P. Gaidhu, and R. B. Ceddia
Inhibition of Insulin-Stimulated Glycogen Synthesis by 5-Aminoimidasole-4-Carboxamide-1-{beta}-D-Ribofuranoside-Induced Adenosine 5'-Monophosphate-Activated Protein Kinase Activation: Interactions with Akt, Glycogen Synthase Kinase 3-3{alpha}/{beta}, and Glycogen Synthase in Isolated Rat Soleus Muscle
Endocrinology, November 1, 2006; 147(11): 5170 - 5177.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Cui, H.-J. Kim, I. Kuiatse, H. Kim, P. H. Brown, and A. V. Lee
Epidermal Growth Factor Induces Insulin Receptor Substrate-2 in Breast Cancer Cells via c-Jun NH2-Terminal Kinase/Activator Protein-1 Signaling to Regulate Cell Migration.
Cancer Res., May 15, 2006; 66(10): 5304 - 5313.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Imoto, D. Kukidome, T. Nishikawa, T. Matsuhisa, K. Sonoda, K. Fujisawa, M. Yano, H. Motoshima, T. Taguchi, K. Tsuruzoe, et al.
Impact of mitochondrial reactive oxygen species and apoptosis signal-regulating kinase 1 on insulin signaling.
Diabetes, May 1, 2006; 55(5): 1197 - 1204.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. Kiens
Skeletal Muscle Lipid Metabolism in Exercise and Insulin Resistance
Physiol Rev, January 1, 2006; 86(1): 205 - 243.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Boden, P. She, M. Mozzoli, P. Cheung, K. Gumireddy, P. Reddy, X. Xiang, Z. Luo, and N. Ruderman
Free Fatty Acids Produce Insulin Resistance and Activate the Proinflammatory Nuclear Factor-{kappa}B Pathway in Rat Liver
Diabetes, December 1, 2005; 54(12): 3458 - 3465.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Weigert, A. M. Hennige, T. Brischmann, A. Beck, K. Moeschel, M. Schauble, K. Brodbeck, H.-U. Haring, E. D. Schleicher, and R. Lehmann
The Phosphorylation of Ser318 of Insulin Receptor Substrate 1 Is Not per se Inhibitory in Skeletal Muscle Cells but Is Necessary to Trigger the Attenuation of the Insulin-stimulated Signal
J. Biol. Chem., November 11, 2005; 280(45): 37393 - 37399.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Varma, B. K. Lal, R. Zheng, J. W. Breslin, S. Saito, P. J. Pappas, R. W. Hobson II, and W. N. Duran
Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1744 - H1751.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
F. S. L. Thong, C. B. Dugani, and A. Klip
Turning Signals On and Off: GLUT4 Traffic in the Insulin-Signaling Highway
Physiology, August 1, 2005; 20(4): 271 - 284.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Jove, A. Planavila, J. C. Laguna, and M. Vazquez-Carrera
Palmitate-Induced Interleukin 6 Production Is Mediated by Protein Kinase C and Nuclear-Factor {kappa}B Activation and Leads to Glucose Transporter 4 Down-Regulation in Skeletal Muscle Cells
Endocrinology, July 1, 2005; 146(7): 3087 - 3095.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-a Kim, D. C. Yeh, M. Ver, Y. Li, A. Carranza, T. P. Conrads, T. D. Veenstra, M. A. Harrington, and M. J. Quon
Phosphorylation of Ser24 in the Pleckstrin Homology Domain of Insulin Receptor Substrate-1 by Mouse Pelle-like Kinase/Interleukin-1 Receptor-associated Kinase: CROSS-TALK BETWEEN INFLAMMATORY SIGNALING AND INSULIN SIGNALING THAT MAY CONTRIBUTE TO INSULIN RESISTANCE
J. Biol. Chem., June 17, 2005; 280(24): 23173 - 23183.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Belfort, L. Mandarino, S. Kashyap, K. Wirfel, T. Pratipanawatr, R. Berria, R. A. DeFronzo, and K. Cusi
Dose-Response Effect of Elevated Plasma Free Fatty Acid on Insulin Signaling
Diabetes, June 1, 2005; 54(6): 1640 - 1648.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Tremblay, A. Gagnon, A. Veilleux, A. Sorisky, and A. Marette
Activation of the Mammalian Target of Rapamycin Pathway Acutely Inhibits Insulin Signaling to Akt and Glucose Transport in 3T3-L1 and Human Adipocytes
Endocrinology, March 1, 2005; 146(3): 1328 - 1337.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Liberman and H. Eldar-Finkelman
Serine 332 Phosphorylation of Insulin Receptor Substrate-1 by Glycogen Synthase Kinase-3 Attenuates Insulin Signaling
J. Biol. Chem., February 11, 2005; 280(6): 4422 - 4428.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
Y. Zick
Ser/Thr Phosphorylation of IRS Proteins: A Molecular Basis for Insulin Resistance
Sci. Signal., January 25, 2005; 2005(268): pe4 - pe4.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y.-F. Liu, A. Herschkovitz, S. Boura-Halfon, D. Ronen, K. Paz, D. LeRoith, and Y. Zick
Serine Phosphorylation Proximal to Its Phosphotyrosine Binding Domain Inhibits Insulin Receptor Substrate 1 Function and Promotes Insulin Resistance
Mol. Cell. Biol., November 1, 2004; 24(21): 9668 - 9681.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Ugi, T. Imamura, H. Maegawa, K. Egawa, T. Yoshizaki, K. Shi, T. Obata, Y. Ebina, A. Kashiwagi, and J. M. Olefsky
Protein Phosphatase 2A Negatively Regulates Insulin's Metabolic Signaling Pathway by Inhibiting Akt (Protein Kinase B) Activity in 3T3-L1 Adipocytes
Mol. Cell. Biol., October 1, 2004; 24(19): 8778 - 8789.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G. Boden and M. Laakso
Lipids and Glucose in Type 2 Diabetes: What is the cause and effect?
Diabetes Care, September 1, 2004; 27(9): 2253 - 2259.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. D. Werner, J. Lee, L. Hansen, M. Yuan, and S. E. Shoelson
Insulin Resistance Due to Phosphorylation of Insulin Receptor Substrate-1 at Serine 302
J. Biol. Chem., August 20, 2004; 279(34): 35298 - 35305.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Z. Gao, X. Zhang, A. Zuberi, D. Hwang, M. J. Quon, M. Lefevre, and J. Ye
Inhibition of Insulin Sensitivity by Free Fatty Acids Requires Activation of Multiple Serine Kinases in 3T3-L1 Adipocytes
Mol. Endocrinol., August 1, 2004; 18(8): 2024 - 2034.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Moeschel, A. Beck, C. Weigert, R. Lammers, H. Kalbacher, W. Voelter, E. D. Schleicher, H.-U. Haring, and R. Lehmann
Protein Kinase C-{zeta}-induced Phosphorylation of Ser318 in Insulin Receptor Substrate-1 (IRS-1) Attenuates the Interaction with the Insulin Receptor and the Tyrosine Phosphorylation of IRS-1
J. Biol. Chem., June 11, 2004; 279(24): 25157 - 25163.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. Weyrich, K. Kapp, G. Niederfellner, M. Melzer, R. Lehmann, H.-U. Haring, and R. Lammers
Partitioning-Defective Protein 6 Regulates Insulin-Dependent Glycogen Synthesis via Atypical Protein Kinase C
Mol. Endocrinol., May 1, 2004; 18(5): 1287 - 1300.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Neid, K. Datta, S. Stephan, I. Khanna, S. Pal, L. Shaw, M. White, and D. Mukhopadhyay
Role of Insulin Receptor Substrates and Protein Kinase C-{zeta} in Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression in Pancreatic Cancer Cells
J. Biol. Chem., February 6, 2004; 279(6): 3941 - 3948.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Bays, L. Mandarino, and R. A. DeFronzo
Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 463 - 478.
[Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Ward, B. Spinelli, M. J. Quon, H. Chen, S. R. Ikeda, and K. Kelly
Phosphorylation of Critical Serine Residues in Gem Separates Cytoskeletal Reorganization from Down-Regulation of Calcium Channel Activity
Mol. Cell. Biol., January 15, 2004; 24(2): 651 - 661.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Miele, A. Riboulet, M. A. Maitan, F. Oriente, C. Romano, P. Formisano, J. Giudicelli, F. Beguinot, and E. Van Obberghen
Human Glycated Albumin Affects Glucose Metabolism in L6 Skeletal Muscle Cells by Impairing Insulin-induced Insulin Receptor Substrate (IRS) Signaling through a Protein Kinase C{alpha}-mediated Mechanism
J. Biol. Chem., November 28, 2003; 278(48): 47376 - 47387.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. R. Bruce, M. J. Anderson, A. L. Carey, D. G. Newman, A. Bonen, A. D. Kriketos, G. J. Cooney, and J. A. Hawley
Muscle Oxidative Capacity Is a Better Predictor of Insulin Sensitivity than Lipid Status
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5444 - 5451.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Li, S. Eitan, J. Wu, C. J. Evans, B. Kieffer, X. Sun, and R. D. Polakiewicz
Morphine Induces Desensitization of Insulin Receptor Signaling
Mol. Cell. Biol., September 1, 2003; 23(17): 6255 - 6266.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Gao, A. Zuberi, M. J. Quon, Z. Dong, and J. Ye
Aspirin Inhibits Serine Phosphorylation of Insulin Receptor Substrate 1 in Tumor Necrosis Factor-treated Cells through Targeting Multiple Serine Kinases
J. Biol. Chem., June 27, 2003; 278(27): 24944 - 24950.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Horike, H. Takemori, Y. Katoh, J. Doi, L. Min, T. Asano, X. J. Sun, H. Yamamoto, S. Kasayama, M. Muraoka, et al.
Adipose-specific Expression, Phosphorylation of Ser794 in Insulin Receptor Substrate-1, and Activation in Diabetic Animals of Salt-inducible Kinase-2
J. Biol. Chem., May 9, 2003; 278(20): 18440 - 18447.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. K. T. Lam, A. Carpentier, G. F. Lewis, G. van de Werve, I. G. Fantus, and A. Giacca
Mechanisms of the free fatty acid-induced increase in hepatic glucose production
Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E863 - E873.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. S. Weigle, D. E. Cummings, P. D. Newby, P. A. Breen, R. S. Frayo, C. C. Matthys, H. S. Callahan, and J. Q. Purnell
Roles of Leptin and Ghrelin in the Loss of Body Weight Caused by a Low Fat, High Carbohydrate Diet
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1577 - 1586.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. R. Wick, E. D. Werner, P. Langlais, F. J. Ramos, L. Q. Dong, S. E. Shoelson, and F. Liu
Grb10 Inhibits Insulin-stimulated Insulin Receptor Substrate (IRS)-Phosphatidylinositol 3-Kinase/Akt Signaling Pathway by Disrupting the Association of IRS-1/IRS-2 with the Insulin Receptor
J. Biol. Chem., February 28, 2003; 278(10): 8460 - 8467.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Jiang, Q. Dallas-Yang, F. Liu, D. E. Moller, and B. B. Zhang
Salicylic Acid Reverses Phorbol 12-Myristate-13-Acetate (PMA)- and Tumor Necrosis Factor alpha (TNFalpha )-induced Insulin Receptor Substrate 1 (IRS1) Serine 307 Phosphorylation and Insulin Resistance in Human Embryonic Kidney 293 (HEK293) Cells
J. Biol. Chem., January 3, 2003; 278(1): 180 - 186.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
R. A Defronzo
Impaired glucose tolerance: do pharmacological therapies correct the underlying metabolic disturbance?
The British Journal of Diabetes & Vascular Disease, January 1, 2003; 3(1_suppl): S24 - S40.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
Z. Gao, D. Hwang, F. Bataille, M. Lefevre, D. York, M. J. Quon, and J. Ye
Serine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor kappa B Kinase Complex
J. Biol. Chem., December 6, 2002; 277(50): 48115 - 48121.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. R. Sedaghat, A. Sherman, and M. J. Quon
A mathematical model of metabolic insulin signaling pathways
Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1084 - E1101.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. Cariou, D. Perdereau, K. Cailliau, E. Browaeys-Poly, V. Bereziat, M. Vasseur-Cognet, J. Girard, and A.-F. Burnol
The Adapter Protein ZIP Binds Grb14 and Regulates Its Inhibitory Action on Insulin Signaling by Recruiting Protein Kinase C{zeta}
Mol. Cell. Biol., October 15, 2002; 22(20): 6959 - 6970.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. G. Kayali, D. A. Austin, and N. J. G. Webster
Rottlerin Inhibits Insulin-Stimulated Glucose Transport in 3T3-L1 Adipocytes by Uncoupling Mitochondrial Oxidative Phosphorylation
Endocrinology, October 1, 2002; 143(10): 3884 - 3896.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Montagnani, L. V. Ravichandran, H. Chen, D. L. Esposito, and M. J. Quon
Insulin Receptor Substrate-1 and Phosphoinositide-Dependent Kinase-1 Are Required for Insulin-Stimulated Production of Nitric Oxide in Endothelial Cells
Mol. Endocrinol., August 1, 2002; 16(8): 1931 - 1942.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. I. Itani, N. B. Ruderman, F. Schmieder, and G. Boden
Lipid-Induced Insulin Resistance in Human Muscle Is Associated With Changes in Diacylglycerol, Protein Kinase C, and I{kappa}B-{alpha}
Diabetes, July 1, 2002; 51(7): 2005 - 2011.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Hemi, K. Paz, N. Wertheim, A. Karasik, Y. Zick, and H. Kanety
Transactivation of ErbB2 and ErbB3 by Tumor Necrosis Factor-alpha and Anisomycin Leads to Impaired Insulin Signaling through Serine/Threonine Phosphorylation of IRS Proteins
J. Biol. Chem., March 8, 2002; 277(11): 8961 - 8969.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. T. Kruszynska, D. S. Worrall, J. Ofrecio, J. P. Frias, G. Macaraeg, and J. M. Olefsky
Fatty Acid-Induced Insulin Resistance: Decreased Muscle PI3K Activation But Unchanged Akt Phosphorylation
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 226 - 234.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Shao, H. Yamashita, L. Qiao, B. Draznin, and J. E. Friedman
Phosphatidylinositol 3-Kinase Redistribution Is Associated With Skeletal Muscle Insulin Resistance in Gestational Diabetes Mellitus
Diabetes, January 1, 2002; 51(1): 19 - 29.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. N. Jakobsen, D. G. Hardie, N. Morrice, and H. E. Tornqvist
5'-AMP-activated Protein Kinase Phosphorylates IRS-1 on Ser-789 in Mouse C2C12 Myotubes in Response to 5-Aminoimidazole-4-carboxamide Riboside
J. Biol. Chem., December 7, 2001; 276(50): 46912 - 46916.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
G. P. Sykiotis and A. G. Papavassiliou
Minireview: Serine Phosphorylation of Insulin Receptor Substrate-1: A Novel Target for the Reversal of Insulin Resistance
Mol. Endocrinol., November 1, 2001; 15(11): 1864 - 1869.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Teruel, R. Hernandez, and M. Lorenzo
Ceramide Mediates Insulin Resistance by Tumor Necrosis Factor-{alpha} in Brown Adipocytes by Maintaining Akt in an Inactive Dephosphorylated State
Diabetes, November 1, 2001; 50(11): 2563 - 2571.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. V. Ravichandran, H. Chen, Y. Li, and M. J. Quon
Phosphorylation of PTP1B at Ser50 by Akt Impairs Its Ability to Dephosphorylate the Insulin Receptor
Mol. Endocrinol., October 1, 2001; 15(10): 1768 - 1780.
[Abstract] [Full Text] [PDF]